Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway.
Pharmacoeconomics
; 36(5): 591-601, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29396744
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Health Care Costs
/
Cost-Benefit Analysis
/
Hepatitis C
/
Drug Therapy, Combination
Type of study:
Health_economic_evaluation
Limits:
Adult
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2018
Type:
Article
Affiliation country:
Norway